Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Ellmen, J; Werner, D; Hakulinen, P; Keiling, R; Fargeot, P; Falkson, G; Bezwoda, WR
   Dose-dependent hormonal effects of toremifene in postmenopausal breast cancer patients
   CANCER CHEMOTHERAPY AND PHARMACOLOGY
   
   J. Ellmen et al., "Dose-dependent hormonal effects of toremifene in postmenopausal breast cancer patients", CANC CHEMOT, 45(5), 2000, pp. 402-408
2. TOMAS E
   TOREMIFENE AND THE UTERUS
   European journal of cancer
   
   E. Tomas, "TOREMIFENE AND THE UTERUS", European journal of cancer, 34, 1998, pp. 58-59
3. TOMINAGA T; NOMURA Y; UCHINO J; HIRATA K; KIMURA M; YOSHIDA M; AOYAMA H; KINOSHITA H; KOYAMA H; MONDEN Y; TAKASHIMA S; OGAWA M
   CYCLOPHOSPHAMIDE, ADRIAMYCIN, 5-FLUOROURACIL AND HIGH-DOSE TOREMIFENEFOR PATIENTS WITH ADVANCED RECURRENT BREAST-CANCER/
   Japanese Journal of Clinical Oncology
   
   T. Tominaga et al., "CYCLOPHOSPHAMIDE, ADRIAMYCIN, 5-FLUOROURACIL AND HIGH-DOSE TOREMIFENEFOR PATIENTS WITH ADVANCED RECURRENT BREAST-CANCER/", Japanese Journal of Clinical Oncology, 28(4), 1998, pp. 250-254
4. BARAL E; NAGY E; KANGAS L; BERCZI I
   COMBINATION THERAPY OF THE H2712 MURINE MAMMARY-CARCINOMA WITH CYTOTOXIC T-LYMPHOCYTES AND ANTIESTROGENS
   Anticancer research
   
   E. Baral et al., "COMBINATION THERAPY OF THE H2712 MURINE MAMMARY-CARCINOMA WITH CYTOTOXIC T-LYMPHOCYTES AND ANTIESTROGENS", Anticancer research, 17(5A), 1997, pp. 3647-3651
5. BARAL E; NAGY E; KANGAS L; BERCZI I
   COMBINATION IMMUNOTHERAPY OF THE P815 MURINE MASTOCYTOMA WITH KILLER-CELLS, IL-2 AND ANTIESTROGENS
   Anticancer research
   
   E. Baral et al., "COMBINATION IMMUNOTHERAPY OF THE P815 MURINE MASTOCYTOMA WITH KILLER-CELLS, IL-2 AND ANTIESTROGENS", Anticancer research, 17(5A), 1997, pp. 3653-3658
6. NAGY E; BARAL E; KANGAS L; BERCZI I
   ANTIESTROGENS POTENTIATE THE IMMUNOTHERAPY OF THE P815 MURINE MASTOCYTOMA BY CYTOTOXIC T-LYMPHOCYTES
   Anticancer research
   
   E. Nagy et al., "ANTIESTROGENS POTENTIATE THE IMMUNOTHERAPY OF THE P815 MURINE MASTOCYTOMA BY CYTOTOXIC T-LYMPHOCYTES", Anticancer research, 17(2A), 1997, pp. 1083-1088
7. HAYES DF; VANZYL JA; HACKING A; GOEDHALS L; BEZWODA WR; MAILLIARD JA; JONES SE; VOGEL CL; BERRIS RF; SHEMANO I; SCHOENFELDER J
   RANDOMIZED COMPARISON OF TAMOXIFEN AND 2 SEPARATE DOSES OF TOREMIFENEIN POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CANCER
   Journal of clinical oncology
   
   D.F. Hayes et al., "RANDOMIZED COMPARISON OF TAMOXIFEN AND 2 SEPARATE DOSES OF TOREMIFENEIN POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CANCER", Journal of clinical oncology, 13(10), 1995, pp. 2556-2566
8. PERRY JJ; BERRY DA; WEISS RB; HAYES DM; DUGGAN DB; HENDERSON IC
   HIGH-DOSE TOREMIFENE FOR ESTROGEN AND PROGESTERONE-RECEPTOR NEGATIVE METASTATIC BREAST-CANCER - A PHASE-II TRIAL OF THE CANCER AND LEUKEMIAGROUP-B (CALGB)
   Breast cancer research and treatment
   
   J.J. Perry et al., "HIGH-DOSE TOREMIFENE FOR ESTROGEN AND PROGESTERONE-RECEPTOR NEGATIVE METASTATIC BREAST-CANCER - A PHASE-II TRIAL OF THE CANCER AND LEUKEMIAGROUP-B (CALGB)", Breast cancer research and treatment, 36(1), 1995, pp. 35-40
9. TOMAS E; KAUPPILA A; BLANCO G; APAJASARKKINEN M; LAATIKAINEN T
   COMPARISON BETWEEN THE EFFECTS OF TAMOXIFEN AND TOREMIFENE ON THE UTERUS IN POSTMENOPAUSAL BREAST-CANCER PATIENTS
   Gynecologic oncology
   
   E. Tomas et al., "COMPARISON BETWEEN THE EFFECTS OF TAMOXIFEN AND TOREMIFENE ON THE UTERUS IN POSTMENOPAUSAL BREAST-CANCER PATIENTS", Gynecologic oncology, 59(2), 1995, pp. 261-266
10. HUOVINEN R; COLLAN Y
    CELL LOSS IN DIMETHYLBENZ(A)ANTHRACENE-INDUCED RAT MAMMARY-CARCINOMA TREATED WITH TOREMIFENE AND OVARIECTOMY
    Tumor biology
    
    R. Huovinen e Y. Collan, "CELL LOSS IN DIMETHYLBENZ(A)ANTHRACENE-INDUCED RAT MAMMARY-CARCINOMA TREATED WITH TOREMIFENE AND OVARIECTOMY", Tumor biology, 15(6), 1994, pp. 345-353
11. SZAMEL I; HINDY I; VINCZE B; ECKHARDT S; KANGAS L; HAJBA A
    INFLUENCE OF TOREMIFENE ON THE ENDOCRINE REGULATION IN BREAST-CANCER PATIENTS
    European journal of cancer
    
    I. Szamel et al., "INFLUENCE OF TOREMIFENE ON THE ENDOCRINE REGULATION IN BREAST-CANCER PATIENTS", European journal of cancer, 30A(2), 1994, pp. 154-158
12. BIEDERMANN E; LOSER R; HASMANN M
    DROLOXIFENE INHIBITS GROWTH AND PROTEIN-S YNTHESIS OF BREAST-CANCER CELLS MORE EFFECTIVELY THAN TAMOXIFEN AND TOREMIFEN
    Onkologie
    
    E. Biedermann et al., "DROLOXIFENE INHIBITS GROWTH AND PROTEIN-S YNTHESIS OF BREAST-CANCER CELLS MORE EFFECTIVELY THAN TAMOXIFEN AND TOREMIFEN", Onkologie, 17, 1994, pp. 17-21
13. YANG DJ; LI C; KUANG LR; PRICE JE; BUZDAR AU; TANSEY W; CHERIF A; GRETZER M; KIM EE; WALLACE S
    IMAGING, BIODISTRIBUTION AND THERAPY POTENTIAL OF HALOGENATED TAMOXIFEN ANALOGS
    Life sciences
    
    D.J. Yang et al., "IMAGING, BIODISTRIBUTION AND THERAPY POTENTIAL OF HALOGENATED TAMOXIFEN ANALOGS", Life sciences, 55(1), 1994, pp. 53-67
14. STENBYGAARD LE; HERRSTEDT J; THOMSEN JF; SVENDSEN KR; ENGELHOLM SA; DOMBERNOWSKY P
    TOREMIFENE AND TAMOXIFEN IN ADVANCED BREAST-CANCER - A DOUBLE-BLIND CROSS-OVER TRIAL
    Breast cancer research and treatment
    
    L.E. Stenbygaard et al., "TOREMIFENE AND TAMOXIFEN IN ADVANCED BREAST-CANCER - A DOUBLE-BLIND CROSS-OVER TRIAL", Breast cancer research and treatment, 25(1), 1993, pp. 57-63
15. HUOVINEN R; WARRI A; COLLAN Y
    MITOTIC-ACTIVITY, APOPTOSIS AND TRPM-2 MESSENGER-RNA EXPRESSION IN DMBA-INDUCED RAT MAMMARY-CARCINOMA TREATED WITH ANTIESTROGEN TOREMIFENE
    International journal of cancer
    
    R. Huovinen et al., "MITOTIC-ACTIVITY, APOPTOSIS AND TRPM-2 MESSENGER-RNA EXPRESSION IN DMBA-INDUCED RAT MAMMARY-CARCINOMA TREATED WITH ANTIESTROGEN TOREMIFENE", International journal of cancer, 55(4), 1993, pp. 685-691